Detalles de la búsqueda
1.
Predicting nonmuscle invasive bladder cancer recurrence and progression in patients treated with bacillus Calmette-Guerin: the CUETO scoring model.
J Urol
; 182(5): 2195-203, 2009 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-19758621
2.
Sequential combination of mitomycin C plus bacillus Calmette-Guérin (BCG) is more effective but more toxic than BCG alone in patients with non-muscle-invasive bladder cancer in intermediate- and high-risk patients: final outcome of CUETO 93009, a randomized prospective trial.
Eur Urol
; 67(3): 508-16, 2015 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-25301758
3.
Long-term results of two prospective bladder-sparing trimodality approaches for invasive bladder cancer: neoadjuvant chemotherapy and concurrent radio-chemotherapy.
Urology
; 80(5): 1056-62, 2012 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-22999456
4.
Long-term results after high-dose radiotherapy and adjuvant hormones in prostate cancer: how curable is high-risk disease?
Int J Radiat Oncol Biol Phys
; 81(5): 1279-85, 2011 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-20932659
5.
The EORTC tables overestimate the risk of recurrence and progression in patients with non-muscle-invasive bladder cancer treated with bacillus Calmette-Guérin: external validation of the EORTC risk tables.
Eur Urol
; 60(3): 423-30, 2011 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-21621906
6.
Is hormone therapy a protective factor for late hematuria after high-dose radiotherapy in prostate cancer?
Urology
; 72(5): 1130-4, 2008 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-18400265
7.
Prognostic factors in patients with non-muscle-invasive bladder cancer treated with bacillus Calmette-Guérin: multivariate analysis of data from four randomized CUETO trials.
Eur Urol
; 53(5): 992-1001, 2008 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-17950987
8.
Has a 3-fold decreased dose of bacillus Calmette-Guerin the same efficacy against recurrences and progression of T1G3 and Tis bladder tumors than the standard dose? Results of a prospective randomized trial.
J Urol
; 174(4 Pt 1): 1242-7, 2005 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-16145378
Resultados
1 -
8
de 8
1
Próxima >
>>